Potential mechanisms of action of lithium in bipolar disorder: Current understanding

GS Malhi, M Tanious, P Das, CM Coulston, M Berk - CNS drugs, 2013 - Springer
Lithium has been used for over half a century for the treatment of bipolar disorder as the
archetypal mood stabilizer, and has a wealth of empirical evidence supporting its efficacy in …

Impaired mitochondrial function in psychiatric disorders

H Manji, T Kato, NA Di Prospero, S Ness… - Nature reviews …, 2012 - nature.com
Major psychiatric illnesses such as mood disorders and schizophrenia are chronic, recurrent
mental illnesses that affect the lives of millions of individuals. Although these disorders have …

Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications

T Dresler, S Caratozzolo, K Guldolf, JI Huhn… - The journal of headache …, 2019 - Springer
Background Migraine is a highly prevalent and disabling neurological disorder which is
commonly linked with a broad range of psychiatric comorbidities, especially among subjects …

Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

PJ Allen - Neuroscience & Biobehavioral Reviews, 2012 - Elsevier
Athletes, body builders, and military personnel use dietary creatine as an ergogenic aid to
boost physical performance in sports involving short bursts of high-intensity muscle activity …

Current understanding of bipolar disorder: Toward integration of biological basis and treatment strategies

T Kato - Psychiatry and clinical neurosciences, 2019 - Wiley Online Library
Biological studies of bipolar disorder initially focused on the mechanism of action for
antidepressants and antipsychotic drugs, and the roles of monoamines (eg, serotonin …

Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta‐analysis

AD Gigante, DJ Bond, B Lafer, RW Lam… - Bipolar …, 2012 - Wiley Online Library
Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, Yatham LN. Brain glutamate levels
measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta …

Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder

AC Andreazza, JF Wang, F Salmasi… - Journal of …, 2013 - Wiley Online Library
Previously, we found decreased mitochondrial complex I subunits levels and increased
protein oxidation and nitration in postmortem prefrontal cortex (PFC) from patients with …

Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings

M Li, T Li, X Xiao, J Chen, Z Hu, Y Fang - Molecular Psychiatry, 2022 - nature.com
Genome-wide association studies (GWAS) have reported substantial genomic loci
significantly associated with clinical risk of bipolar disorder (BD), and studies combining …

Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis

N Yoshimi, T Futamura, SE Bergen, Y Iwayama… - Molecular …, 2016 - nature.com
Although evidence for mitochondrial dysfunction in the pathogenesis of bipolar disorder
(BD) has been reported, the precise biological basis remains unknown, hampering the …

Genome-wide association study of bipolar I disorder in the Han Chinese population

MTM Lee, CH Chen, CS Lee, CC Chen… - Molecular …, 2011 - nature.com
We report the first genome-wide association study in 1000 bipolar I patients and 1000
controls, with a replication of the top hits in another 409 cases and 1000 controls in the Han …